| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 17.29 Billion | USD 37.51 Billion | 8.2% | 2024 |
What will be the global point of care diagnostics market size during the forecast period?
The global point of care diagnostics market size was worth around USD 17.29 billion in 2024 and is predicted to grow to around USD 37.51 billion by 2034, with a compound annual growth rate (CAGR) of roughly 8.2% between 2025 and 2034.
This report provides a comprehensive analysis of the growth drivers, restraints, and challenges shaping demand across the global point of care diagnostics market throughout the forecast period, while highlighting high-potential emerging opportunities within the industry.
As per the analysis shared by our research analyst, the global point of care diagnostics market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2025-2034).
In terms of revenue, the global point of care diagnostics market size was valued at around USD 17.29 billion in 2024 and is projected to reach USD 37.51 billion by 2034.
The point of care diagnostics market is projected to grow at a significant rate due to increasing demand for rapid and convenient diagnostic solutions, the rising prevalence of chronic diseases, and advancements in portable and user-friendly diagnostic technologies.
Based on the product segment, the glucose monitoring kits segment is expected to lead the global market because of the high and growing prevalence of diabetes that requires frequent self-monitoring and clinical assessment.
Based on the prescription mode segment, prescription-based testing kits hold a substantial share as many clinical and hospital-based assays require professional oversight, while over-the-counter kits expand access for home and consumer use.
Based on the end user segment, hospitals and clinics account for a major portion of demand due to the need for rapid decision-making in acute and chronic care settings, with ambulatory care settings also contributing meaningfully.
Based on the region, North America is predicted to dominate the global market during the forecast period, supported by advanced healthcare infrastructure, high adoption of rapid diagnostics, and strong reimbursement frameworks.
Point-of-care diagnostics (POCD) is critical for detecting analytes close to the patient, allowing for improved illness monitoring, diagnosis, and management. It allows for rapid medical choices since illnesses can be detected at an early stage, resulting in better health outcomes for patients by allowing for the early initiation of therapy. The point of Care diagnostics is medical testing performed at a clinical laboratory close to where the patient is receiving care. POCT is usually performed by non-laboratory personnel, and the results are used for clinical decision-making. Point-of-care technologies may enhance the management of different diseases and conditions.
Point-of-care diagnostics is of great importance in developing countries. Unfortunately, a major aspect in developing countries is that they often lack modern laboratories and fully automated instruments that provide highly reproducible, quantitative, and hence sensitive and accurate diagnostic results. To circumvent these issues, the emergence of rapid and easy-to-use point-of-care (POC) tests can dramatically enhance a physician’s ability to diagnose patients’ diseases rapidly and accurately.
Rise in the prevalence of infectious and chronic diseases is fostering market growth
Globally, the burden of infectious and chronic diseases is on the rise. Lack of exercise, changes in lifestyle, and unhealthy habits are also some of the factors that are leading to an increase in chronic diseases like diabetes, chronic respiratory diseases, and cardiovascular diseases. According to WHO, cardiovascular disease constitutes the majority of non-communicable disease mortality (17.9 million per year), followed by cancer (9.3 million), respiratory infections (4.1 million), and diabetes (1.5 million). Additionally, two-thirds of all tuberculosis cases worldwide were traced to just eight countries: South Africa, Bangladesh, Nigeria, Pakistan, the Philippines, China, Indonesia, and India. POC diagnostics can considerably enhance the treatment of infectious illnesses, particularly in underdeveloped nations where prompt medical care is difficult to come by and healthcare infrastructure is limited.
Furthermore, government incentives and grants for the introduction of new products are driving the use of modern technology for infectious disease diagnostics. These efforts have made it simpler for people in undeveloped and impoverished nations to afford these tests. Moreover, factors such as the increasing number of clinics implementing POC diagnostics for the quick identification of infectious diseases are likely to fuel the growth of the global point of care diagnostics market.
Lack of trained professionals in the diagnostic field hampers market growth
According to WHO research, a worldwide health concern is a shortage of healthcare workers, which affects access to healthcare services. Low- and middle-income countries are further hampered by a shortage of trained health professionals, and innovations, such as the adoption of POC diagnostics in medical care, are posing challenges to POCT delivery due to the increasing workload and dearth of skilled health workers.
Smart devices equipped with mobile healthcare (mH) to pave the way for market expansion
The current POCD trend is firmly leaning toward smart devices integrated with mobile healthcare, which have the potential to genuinely transform customized healthcare monitoring and management, opening the way for next-generation point-of-care diagnostics. Smartphone POC technologies for the interpretation of colorimetric, chemiluminescent, fluorescence, electrochemical, label-free, and lateral flow assays detection of cells, nanoparticles, biomolecules, and microbes; and other diagnostic applications have previously been developed.
The number of cellphone users has now surpassed 7.4 billion, with 70 percent of them living in poor nations with a severe need for POCD. Numerous smartphone gadgets and smart applications for managing and monitoring fundamental health metrics such as blood pressure, blood glucose, pulse rate, body analysis, physical activity, weight, and electrocardiogram have been commercialized. All these factors ensure the healthy growth of the global point of care diagnostics market during the forecast period.
The market is likely to face challenges due to high test costs compared to laboratory tests
One of the major challenges for the global point of care diagnostics market is its high cost as compared to laboratory tests. Rural areas and underdeveloped nations still prefer laboratory testing over POC diagnostics which in turn is limiting the market growth. Also, unfavorable reimbursement policies for POC diagnostics have led to low penetration of the market in emerging countries.
| Report Attributes | Report Details |
|---|---|
| Report Name | Point of Care Diagnostics Market |
| Market Size in 2024 | USD 17.29 Billion |
| Market Forecast in 2034 | USD 37.51 Billion |
| Growth Rate | CAGR of 8.2% |
| Number of Pages | 260 |
| Key Companies Covered | Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, Quidel Diagnostics, Trinity Biotech, EKF Diagnostics, Fluxergy, and others. |
| Segments Covered | By Product, By Prescription Mode, By End User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
| Base Year | 2024 |
| Historical Year | 2020 - 2023 |
| Forecast Year | 2025 - 2034 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The point of care diagnostics market is segmented by product, prescription mode, end user, and region. All segments of the point of care diagnostics market have been analyzed based on present and future trends and the market is estimated from 2025 to 2034.
Based on product, the market can be segmented into glucose monitoring kits, cardiometabolic monitoring kits, infectious diseases testing kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and others. Glucose monitoring kits held a 40% share of the overall market in terms of revenue in 2024. The increasing prevalence of diabetes across the globe is expected to boost the demand for glucose testing in the years to come. The infectious disease testing kits are expected to grow at the highest CAGR during the forecast period on account of the rise in the number of HIV-infected individuals.
Based on prescription mode, the market is divided into prescription-based testing kits and over-the-counter testing kits. Prescription-based kits hold a major share because many clinical assays used in hospitals, clinics, and ambulatory settings require professional oversight and regulatory clearance for medical decision-making. Over-the-counter kits expand consumer access for home monitoring of glucose, pregnancy, fertility, and selected other parameters, supporting self-management and reducing pressure on formal healthcare facilities. The combination of professional and consumer channels broadens market reach and drives innovation in both regulated clinical platforms and user-friendly home testing formats.
Based on the end-user, the market can be segmented into hospitals, clinics, and ambulatory care settings. The hospitals and clinics segment was the leading segment, and it accounted for a large chunk of the market share in 2024. Increasing adoption of these tests in the clinics for diagnosis of several infections and monitoring of disease progression by assessment of symptoms and other parameters is expected to boost the demand for POCT in this segment. Home health care is another important segment of this market.
North America is expected to remain the largest market for point of care diagnostics during the forecast period. Key factors propelling the growth of the market in the region include an increase in the upper-class population, increasing cases of chronic disorders due to changes in food habits & lifestyle, and growing demand for effective and efficient diagnostics. Further, healthcare infrastructure in major countries in the region such as the US and Canada is well developed and supports advanced treatment & diagnostics systems.
Moreover, high spending power on medical treatments is well supported by increasing initiatives by private and public hospitals in the region. Asia Pacific is projected to provide plenty of opportunities for the expansion of the point of care diagnostics market. Large middle-class populations with frequent health problems are triggering the need for efficient diagnostic systems. Besides, increasing awareness regarding POC diagnostics in emerging countries such as India and China is expected to fuel the market growth over the forecast period.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the point of care diagnostics market on a global and regional basis.
Key players with a major share in the global point of care diagnostics market include;
The global point of care diagnostics market is segmented as follows;
By Product
By Prescription Mode
By End User
By Region
FrequentlyAsked Questions
Point of care diagnostics refers to medical testing performed near or at the site of patient care. It enables rapid detection of analytes, supports earlier diagnosis and treatment decisions, and improves disease monitoring and management, particularly in settings where centralized laboratory access is limited or delayed results would compromise care.
Key drivers include the rising prevalence of infectious and chronic diseases, increasing demand for rapid and convenient diagnostic solutions, advancements in portable and user-friendly technologies, government incentives for new products, and growing adoption of point of care testing in clinics and primary care settings.
The global point-of-care diagnostics market is projected to grow at a CAGR of approximately 8.2% between 2025 and 2034.
North America is expected to dominate the point of care diagnostics market over the forecast period.
Leading players in the global point of care diagnostics market include Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, Quidel Diagnostics, Trinity Biotech, EKF Diagnostics, Fluxergy, and others.
Emerging trends include the expansion of molecular and multiplex point of care platforms, integration of smart devices with mobile healthcare for connected monitoring, development of compact systems that deliver laboratory-quality results in primary care settings, and growth in over-the-counter and home-use testing options.
The report explores crucial aspects of the point-of-care diagnostics market, including a detailed discussion of existing growth factors and restraints, as well as future growth opportunities and challenges.
HappyClients